Peter Radovich - 21 Jan 2026 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
21 Jan 2026
Net transactions value
-$222,301
Form type
4
Filing time
23 Jan 2026, 17:30:08 UTC
Previous filing
18 Mar 2025
Next filing
27 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Radovich Peter PRESIDENT AND COO C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY /s/ Judit Ryvkin, Attorney-in-Fact 23 Jan 2026 0001650131

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Options Exercise +4,167 +22% 23,061 21 Jan 2026 Direct F1, F2
transaction MIRM Common Stock Sale $222,301 -2,382 -10% $93.33 20,679 22 Jan 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Restricted Stock Units Options Exercise $0 -4,167 -33% $0.000000 8,333 21 Jan 2026 Common Stock 4,167 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
F2 Includes 222 shares of common stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.
F3 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
F4 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.